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All metazoan guts are subjected to immunologically
unique conditions in which an efficient antimicrobial
system operates to eliminate pathogens while toler-
ating symbiotic commensal microbiota. However,
the molecular mechanisms controlling this process
are only partially understood. Here, we show that
bacterial-derived uracil acts as a ligand for dual oxi-
dase (DUOX)-dependent reactive oxygen species
generation in Drosophila gut and that the uracil pro-
duction in bacteria causes inflammation in the gut.
The acute and controlled uracil-induced immune
response is required for efficient elimination of bac-
teria, intestinal cell repair, and host survival during
infection of nonresident species. Among resident
gut microbiota, uracil production is absent in symbi-
onts, allowing harmonious colonization without
DUOX activation, whereas uracil release from oppor-
tunistic pathobionts provokes chronic inflammation.
These results reveal that bacteria with distinct abili-
ties to activate uracil-induced gut inflammation, in
terms of intensity and duration, act as critical factors
that determine homeostasis or pathogenesis in gut-
microbe interactions.INTRODUCTION
The gut epithelia of most metazoan organisms harbor complex
microbial communities that range from autochthonous bacteria
to allochthonous bacteria (Dillon and Dillon, 2004; Ley et al.,
2008). Autochthonous bacteria have evolutionarily adapted to
the host gut environment and are capable of permanently colo-
nizing the gut, whereas allochthonous bacteria introduced from
external environments transiently interact with gut epithelia bypassing through the alimentary flowing stream (Savage, 1977).
To adapt to these highly diverse microbial populations in the
gut, hosts have evolved to modulate the gut-innate immunity
to achieve gut-microbe homeostasis by balancing between an
efficient immune response to potentially pathogenic allochtho-
nous bacteria and immune tolerance to symbiotic autochtho-
nous bacteria (Artis, 2008; Sansonetti, 2004). However, this is
a paradoxical situation from the classical view point of innate
immunity because host immune cells should be able to
mount an antimicrobial response against any microorganism,
regardless of whether it is commensal or pathogenic, by sensing
universal microbe-associated molecular patterns (MAMPs)
(Beutler, 2004; Lemaitre and Hoffmann, 2007). Several models
have been proposed in mammals and Drosophila to explain
host immune tolerance to symbiotic gut bacteria. These models
includes restricted expression and compartmentalization of
pattern recognition receptors, multiple mechanisms to down-
regulate NF-kB-dependent innate immune signaling, and com-
partmentalization of gut bacteria by the mucus layer (Hooper,
2009; Lhocine et al., 2008; Paredes et al., 2011; Ryu et al.,
2008). However, the molecular mechanism determining how
the gut tolerates symbiotic bacteria without mounting inflamma-
tion remains to be elucidated.
Drosophila has proven to be a model of choice in terms of un-
derstanding evolutionarily conserved mechanisms underlying
host-microbe homeostasis in the barrier epithelia (Apidianakis
and Rahme, 2011; Bae et al., 2010; Broderick and Lemaitre,
2012; Chambers and Schneider, 2012; Charroux and Royet,
2012). Recent studies have shown that the Drosophila gut is
able to produce two distinct antimicrobial effector molecules,
microbicidal reactive oxygen species (ROS) and antimicrobial
peptide (AMP), to control bacteria (Bae et al., 2010; Lemaitre
and Hoffmann, 2007). It has been demonstrated that the dual
oxidase (DUOX), a member of the nicotinamide adenine dinucle-
otide phosphate (NADPH) oxidase family, plays a pivotal role in
controlling opportunistic pathogens in the gut by inducing de
novo generation of microbicidal ROS (Ha et al., 2005, 2009a,
2009b). Genetic analyses revealed that two DUOX-regulatoryCell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc. 797
pathways function in efficient pathogen-induced ROS produc-
tion; the ‘‘DUOX-activity pathway’’ involving Gaq-PLCb-Ca2+-
mediated signaling modulates DUOX enzymatic activity,
whereas the ‘‘DUOX-expression pathway’’ modulates DUOX
gene induction through sequential activation of MEKK1-MKK3-
p38 MAPK (Ha et al., 2009a, 2009b). Beyond microbicidal
effects, DUOX-dependent ROS were also shown to be involved
directly or indirectly in the epithelial cell renewal program through
activation of intestinal stem cells during gut infection (Buchon
et al., 2009a; Lee, 2009). In addition to DUOX-dependent gut
immunity, pathogen infection can also activate the immune
deficiency (IMD) pathway and subsequent nuclear localization
of the Relish, the p105-like NF-kB, which in turn leads to de
novo production of AMPs (Lemaitre and Hoffmann, 2007). It is
likely that the DUOX-dependent ROS and IMD-dependent
AMPs function in a synergistic and/or complementary manner
in the gut (Ryu et al., 2006).
The regulation of the intestinal IMD pathway has been exten-
sively studied. Bacterial-derived peptidoglycan acts as the only
known MAMP for IMD pathway activation (Leulier et al., 2003;
Royet et al., 2011). In the presence of peptidoglycan derived
from symbiotic autochthonous microbiota, IMD pathway activa-
tion leads to chronic nuclear translocation of Relish, but AMP
expression is actively repressed by various negative regulatory
molecules including Caudal (Lhocine et al., 2008; Paredes
et al., 2011; Ryu et al., 2008). In this model, the IMD pathway is
able tomaintain low level of activation that enables gut to tolerate
commensal bacteria. The Caudal-mediated AMP repression is
shown to be required for protection of commensal bacterial
community (Ryu et al., 2008). Upon gut infection, additional
peptidoglycan derived from high pathogen density can lead to
extra-activation of Relish, which in turn induces AMP expression.
In contrast to peptidoglycan-induced IMD activation, peptido-
glycan is unable to activate DUOX activity (Bae et al., 2010; Ha
et al., 2009b). It has been proposed that the bacterial-derived
ligand for DUOX activation other than peptidoglycan activates
DUOX-regulatory pathways through G-protein-coupled receptor
(GPCR) (Bae et al., 2010; Ha et al., 2009b). Despite the presence
of extremely efficient DUOX-dependent antimicrobial responses
to pathogenic allochthonous bacteria, symbiotic autochthonous
bacteria can still colonize the gut without DUOX activation and
play their part in maintaining gut-microbe mutualisms (Bae
et al., 2010). However, the microbe-derived factors involved in
the activation of DUOX-mediated gut immunity have not yet
been determined.
In this study, we provide evidence that bacterial-derived uracil
acts as a DUOX-activating ligand in the Drosophila gut epithelia.
We showed that uracil released by allochthonous bacteria in-
duces homeostatic inflammation, which is required for pathogen
clearance and host survival. We further found that some patho-
bionts, resident autochthonous bacterial species having con-
ditionally pathogenic characteristics, release uracil, which
chronically activates DUOX-dependent gut immunity leading
to pathology reminiscent of inflammatory bowel diseases. In
contrast to pathobionts, the absence of uracil in symbiotic resi-
dent bacteria allows for peaceful colonization. Our studies illus-
trate how Drosophila mounts DUOX-dependent gut immunity in
response to opportunistic pathogens, how commensal bacteria798 Cell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc.colonize the gut without immune activation, and how certain
commensal bacteria initiate chronic inflammation.
RESULTS
Opportunistic Pathogens, but Not Commensal Bacteria,
Activate DUOX-Dependent Gut Immunity
To determine if the intensity of the host DUOX-dependent
immune response is distinct following different microbial con-
tacts (i.e., symbiotic bacteria or opportunistic pathogen), we
examined bacterial-induced microbicidal ROS production in
the gut. For the in vivo ROS imaging, a specific and sensitive
method for DUOX-dependent ROS detection was used, which
was based on a recently developed rhodamine-based sensor,
R19S (Chen et al., 2011). R19S is highly specific to DUOX-
dependent HOCl and is unable to react with various other ROS
(Chen et al., 2011) including hypothiocyanite (Figure S1A avail-
able online). Drosophila adults were subjected to oral ingestion
with Erwinia carotovora subsp. carotovora-15, a well-known
naturally occurring Drosophila pathogen (Buchon et al., 2009b).
E. carotovora is considered to be an opportunistic pathogen in
Drosophila because it does not harm the normal host but can
cause severe lethality when the host’s DUOX-dependent gut
immunity is impaired (Ha et al., 2005, 2009a, 2009b). As ex-
pected, E. carotovora was able to induce DUOX-dependent
ROS generation at 1–3.5 hr following bacterial ingestion mainly
in the anterior midgut region (Figures 1A, S1B, and S1C). Impor-
tantly, however, bacterial-induced ROS generation was at a
basal level when flies were fed on major symbiotic gut bacteria
(such as Commensalibacter intestini A911T, Acetobacter pomo-
rum, and Lactobacillus plantarum, which account for more than
98% of the total commensal population of our laboratory
Drosophila; Roh et al., 2008; Ryu et al., 2008) (Figure 1A). Further
analyses showed that intestinal ROS generation was specifically
induced by diverse ranges of opportunistic pathogens but
mostly absent to distinct bacterial species that act as com-
mensal microbiota in Drosophila (Figure S1D). This observation
suggests that distinction between commensal and pathogenic
bacteria in Drosophila can be made on the basis of the in vivo
DUOX-activating ability of each bacterium. In contrast to live or
lysed E. carotovora, formalin-fixed dead E. carotovora did not
efficiently induce ROS generation, suggesting that a molecule
secreted from bacteria is responsible for DUOX activation (Fig-
ures 1B and S1E). To test the possible existence of bacterial-
secreted ligands for DUOX activation, we prepared culture
supernatant of different bacterial species. Because we found
that complete bacterial growth media, such as Luria-Bertani
medium, could also induce intestinal ROS generation, all of the
bacteria used in these experiments were grown on minimal
growth media, except for A. pomorum and L. plantarum due to
their total absence of growth in the minimal growth media. We
found that E. carotovora culture supernatants effectively induced
ROS generation in a DUOX-dependent manner, whereas
C. intestini culture supernatants did not (Figure 1C). In contrast
to this differential activation of DUOX-dependent gut immunity,
culture supernatants of both E. carotovora and C. intestini led
to comparable levels of IMD pathway activation in the sys-
temic immunity as evidenced by the similar induction levels of
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Figure 1. An Opportunistic Pathogen, but Not Commensal Bacteria, Secretes a Ligand Capable of Activating DUOX-Dependent Gut
Immunity
(A–C) DUOX-dependent intestinal ROS generation following ingestion for 1.5 hr with live bacteria (A), formalin-fixed dead bacteria (B), or bacterial culture
supernatant (C). ROS production in the anterior midgut was analyzed by HOCl-specific R19S dye. The following fly lines were used: w1118 (Control) and UAS-
DUOX-RNAi/+; Da-GAL4 (DUOX-RNAi). Data were analyzed using an ANOVA followed by Tamhane’s T2 post hoc test; values represent mean ±SEM (*p < 0.05,
**p < 0.005, ***p < 0.001). N.S. denotes not significant.
(D) Systemic IMD pathway activation. Dipt expression was analyzed by quantitative PCR (qPCR) (±SEM) and LacZ staining at 9 hr postinjection. Flies carrying
Dipt-lacZ (Control) and Dipt-lacZ; imd1 (IMD/) were used.
(E) Intestinal IMD pathway activation. Cec expression was analyzed by qPCR (±SEM) following oral infection with live bacteria or formalin-fixed dead bacteria
(1010 bacterial cells) for 9 hr.
See also Figure S1.
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Figure 2. Uracil as a Pathogen-Derived Ligand Capable of Activating DUOX-Dependent Gut Immunity
(A) Purification of E. carotovora ROS-inducing factor by HPLC analysis. ROS production in the anterior midgut was analyzed following ingestion of HPLC-purified
fractions (1.5 hr). Data are analyzed using an ANOVA followed by Tukey’s post hoc test; values represent mean ±SEM (***p < 0.001). Peaks of interest (peaks
indicated by asterisks) were subjected to spectrum analysis by using a photodiode array detector (blue boxed).
(B) Uracil activates intestinal PLCb. Transgenic flies carrying UAS-PLCb-RFP; Da-GAL4 were used following uracil ingestion (20 nM for 2 hr).
(legend continued on next page)
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Relish/NF-kB-dependent AMP gene expression in the fat body
(Figure 1D). Furthermore, gut infection experiments with live
bacteria, but not formalin-fixed dead bacteria, showed that
both Gram-negative pathogens and Gram-negative commensal
bacteria induced similar intestinal IMD pathway activation (Fig-
ure 1E). These findings indicate that both E. carotovora and
C. intestini secrete similar levels of peptidoglycan, the known
IMD-pathway-activating MAMP (Lemaitre and Hoffmann,
2007). Taken together, these findings indicate that two distinct
mechanisms, the IMD pathway and the DUOX-activation path-
way, are operating concomitantly to mount an immune response
against pathogens. As E. carotovoara, but not C. intestini, is
able to induce DUOX activation, E. carotovora may secrete an
unknown ligand(s) for intestinal DUOX activation.
The E. carotovora-Derived DUOX-Activating Ligand Is
Bacterial Uracil
To determine the molecular nature of DUOX-activating ligands,
E. carotovora culture supernatant was purified by reverse-phase
high-performance liquid chromatography (HPLC). The DUOX-
activating and ROS-inducing ability of HPLC-purified fractions
was examined, and a fraction found in the E. carotovora culture
supernatant was shown to strongly induce in vivo ROS genera-
tion in the gut epithelia, whereas a peak with the similar retention
time in the C. intestini culture supernatants did not show any
activity (Figure 2A). This HPLC-purified fraction was subse-
quently subjected to structure analyses by mass spectrometry
and nuclear magnetic resonance (NMR). Chemical analyses
revealed that this fraction contained uracil (Figures S2A and
S2B). When the HPLC-purified uracil was compared with syn-
thetic uracil by spectrum analysis (Figure 2A) and NMR analysis
(Figure S2C), the profiles were indistinguishable, confirming that
the pathogen-derived DUOX-activating ligand is uracil. To
further investigate whether uracil release occurs in a wide range
of bacteria including human pathogens, we performed quantita-
tive analysis of uracil in the supernatant of in vitro cultured bac-
teria by using liquid chromatography tandemmass spectrometry
(LC-MS/MS). As complete medium such as Luria-Bertani
medium is found to contain high amounts of uracil (10 mg/ml),
minimal growth media were used to measure the secreted uracil
level from the bacteria. Only seven bacterial species were
capable of growing in the minimal media among 32 tested
bacteria, and their culture supernatants were subjected to the
LC-MS/MS analysis. The result showed that pathogens such
as Vibrio fluvialis, Klebsiella pneumoniae, Shigella sonnei, Pseu-
domonas aeruginosa, and Serratia marcescens secreted signifi-
cant amounts of uracil (70–150 ng/108 cells) (Figure S2D).
Consistent to the above results (Figure 2A), E. carotovora
secreted high amounts of uracil (200 ng/108 cells), whereas
C. intestini did not (Figure S2D). Although the uracil amounts(C) Uracil induces intracellular Ca2+ in Drosophila S2 cells. Uracil (20 nM) was ad
(D and E) Uracil induces p38 activation andDUOX expression. Thew1118 flies (Con
following uracil ingestion (20 nM for 2 hr) (D). DUOX expression levels were mea
(F) Uracil induces PLCb-DUOX-dependent ROS generation. ROS production wa
were used:w1118 (Control), UAS-DUOX-RNAi/+; Da-GAL4 (DUOX-RNAi), and norp
post hoc test; values represent mean ±SEM (**p < 0.005).
See also Figure S2.released from in vitro cultured bacteria do not necessarily reflect
the in vivo uracil release in an epithelial-contacting condition, we
could confirm that each bacterium secretes distinct amounts of
uracil, a DUOX-activating ligand.
Uracil Is a Specific Agonist for the DUOX-Dependent
Gut-Innate Immunity
We have previously proposed that unknown microbe-derived
ligands other than peptidoglycan activate the two DUOX-regula-
tory pathways in Drosophila gut epithelia (Ha et al., 2009a,
2009b). Because bacterial-derived uracil is capable of producing
intestinal ROS, the effect of uracil on the activation of one or both
of these pathways was examined. The result showed that uracil
ingestion can activate both the DUOX-activity pathway (PLCb
activation as evidenced by membrane localization of the active
form of PLCb and by Ca2+ mobilization) (Figures 2B and 2C)
and the DUOX-expression pathway (p38 MAPK activation and
DUOX gene induction) (Figures 2D and 2E). Uracil-induced acti-
vation of both DUOX-regulatory pathways led to the generation
of large amounts of intestinal ROS in a PLCb-DUOX signaling-
dependent manner (Figure 2F). The presence of commensal
bacteria in the gut could not inhibit the ROS-generating ability
of uracil, indicating that commensal bacteria are unable to sup-
press uracil-induced ROS generation (Figure S2E). Coingestion
of uracil with an antioxidant chemical, N-acetyl-cysteine, abol-
ished the detection of DUOX-dependent ROS (Figure S2F).
Dose-dependent analysis showed that uracil is capable of
inducing intestinal ROS generation from 0.01 nM and most
effectively in a range of 1–20 nM (Figure 3A). When we tested
the ROS-inducing ability of various uracil-related molecules
(other purine and pyrimidine nucleobases as well as eight
different pyrimidine analogs including 5-fluorouracil), we found
that only uracil is capable of activating DUOX (Figures 3A and
3B), demonstrating the high specificity of uracil in DUOX-depen-
dent ROS generation in Drosophila gut epithelia. Furthermore,
uracil was also able to activate DUOX-dependent ROS genera-
tion in Caenorhabditis elegans and human mucosal epithelial
cells (Figures S2G–S2I). At present, it is not known how uracil
activates PLCb-induced Ca2+ for DUOX-dependent ROS
generation. Given that Gaq protein is also required for uracil-
induced ROS generation (Figure 3C) and that Gaq-PLCb-Ca2+
pathway acts as one of the main downstream signaling events
of GPCRs (Selbie and Hill, 1998), involvement of specific GPCRs
responsible for uracil recognition is plausible. In contrast to
their abilities to activate the DUOX pathway, uracil was unable
to activate the intestinal IMD pathway leading to AMP produc-
tion (Figure 3D). These results demonstrate that uracil is a spe-
cific agonist for the gut-innate immunity capable of inducing
DUOX-dependent ROS production but not IMD-dependent
AMP production.ded at a specific time point (indicated by an arrow).
trol) andMEKK1mutant flies (MEKK1/) were used for phospho-p38 analysis
sured by qPCR analysis (±SEM, **p < 0.005) at 1 hr postingestion (E).
s examined following uracil ingestion (20 nM for 1.5 hr). The following fly lines
A7 (PLCb/). Data were analyzed using an ANOVA followed by Tamhane’s T2
Cell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc. 801
BD
A ***
0
10
20
30
40
50
60
70
80
R
19
S-
po
sit
ive
 g
ut
 (%
)
N.S.
0.001  0.01  0.1   1   10    20
nM
0.001  0.01  0.1   1    10     20
nM
0.001 0.01  0.1    1    10    20
nM
0.001  0.01  0.1   1    10    20
nM
0.001  0.01  0.1   1    10    20
nM
Adenine Cytosine Guanine Thymine Uracil
None
90
N.S.
0
10
20
30
40
50
60
70
80
***
No
ne
ura
cil
2,4
-dih
ydr
oxy
pyr
idin
e
dih
ydr
our
aci
l
4,6
-dih
ydr
oxy
pyr
imi
din
e
5-e
thy
l-2-
thio
ura
cil
5-b
rom
our
aci
l
2,4
-dic
hlo
rop
yrim
idin
e
5-fl
uor
our
aci
l
R
19
S-
po
sit
ive
 g
ut
 (%
)
90
C
10
20
30
40
50
60
70
80
R
19
S-
po
sit
ive
 g
ut
 (%
)
0
None Uracil None Uracil
Control Gαq
***
N.S.
-/-
90
urid
ine
Ce
c 
m
R
N
A 
(re
lat
ive
 ex
pre
ss
ion
) 10
8
6
4
2
0
***
No
ne
Ura
cil
N.S.
E. 
ca
rot
ov
ora
Figure 3. Uracil Is a Specific Agonist for the DUOX-Dependent Gut-Innate Immunity
(A and B) ROS production was examined following ingestion of different nucleobases (A) and pyrimidine analogs (20 nM for each) (B) for 1.5 hr.
(C) Gaq is required for uracil-induced ROS generation. Flies under a w1118 (Control) or Gaq mutant (Gaq/) background were used for ROS analysis following
uracil ingestion (20 nM for 1.5 hr).
(D) Uracil is unable to activate the intestinal IMD pathway. Cec expression was analyzed by qPCR (±SEM; ***p < 0.001) following oral ingestion with uracil (20 nM)
or live bacteria (1010 bacterial cells) for 4 hr.
Data in (A)–(C) were analyzed using an ANOVA followed by Tamhane’s T2 post hoc test; values represent mean ±SEM (***p < 0.001). See also Figure S2.The Host Mounts DUOX-Dependent Gut Immunity by
Sensing Bacterial-Derived Uracil In Vivo
All of above findings suggest that the gut epithelia selectively
mount a DUOX-dependent antimicrobial program against path-
ogens by sensing pathogen-derived uracil. We reasoned that if
this were the case, opportunistic pathogens lacking uracil pro-
duction would evade DUOX immunity and become virulent to
the host. To assess the role of pathogen-released uracil on802 Cell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc.DUOX activation in an in vivo context, we examined intestinal
ROS generation following infection with a uracil auxotrophic
mutant (URA) pathogen devoid of uracil biosynthesis ability.
For this, we performed a transposon Tn5-mediated random
mutagenesis to generate an E. carotovora mutant library and
subsequently isolated a single URA strain by screening
6,000 mutant strains (Figure S3A). Sequencing analysis
showed that this URA strain had a Tn5 insertion within the
orotate phosphoribosyltransferase gene (pyrE, a gene involved
in uracil biosynthesis) (Figure S3B). No apparent morphological
and/or physiological differences were found between the wild-
type (WT) and URA strain (Figures S3C–S3F) when these
bacteria were cultured in vitro. Furthermore, both WT and
URA strain induced IMD-dependent systemic and intestinal
AMP expression at similar levels (Figures S3G and S3H). Impor-
tantly, gut infection experiments showed that this pyrE mutant
strain (E. carotovora-pyrE::Tn5), but not other nucleobase
mutant strains such as guanine and adenine auxotrophic
mutants, had significantly reduced ROS production when com-
pared to the gut infection with parental WT E. carotovora strain
(Figures 4A, S3I, and S3J). Furthermore, a normal level of infec-
tion-induced ROS in the gut was seen following either coinges-
tion of uracil with URA strains or ingestion of functionally
rescued URA strains (i.e., E. carotovora-pyrE::Tn5 strains that
ectopically express pyrE) (Figure 4A). These results demon-
strated that the host mounts DUOX-dependent gut immunity
by sensing bacterial-derived uracil in vivo.
Bacterial-Derived Uracil Is Responsible for Stem Cell
Modulation and Gut Cell Homeostasis during Gut
Infection
Recently, epithelial damage associatedwith bacterial infection in
the gut was shown to accelerate the renewal program of enter-
ocytes through intestinal stem cell (ISC) stimulation, which is
essential for gut cell homeostasis and host survival against infec-
tion (Buchon et al., 2009a; Chatterjee and Ip, 2009; Cronin et al.,
2009; Jiang et al., 2009). Because DUOX-dependent ROS have
recently been shown to be involved in controlling ISC turnover
during gut infection (Buchon et al., 2009a; Lee, 2009), we deter-
mined if uracil is the bacterial-derived ligand that controls the
epithelial cell renewal program. To accomplish this, we per-
formed gut infection experiments with WT or URA strain and
analyzed escargot-positive cells using the escargot-GAL4 >
UAS-GFP system, which allows the identification of ISCs, enter-
oblasts, and newly synthesized enterocytes (Buchon et al.,
2009a; Chatterjee and Ip, 2009; Jiang et al., 2009). The results
showed that high numbers of escargot-positive cells were
present in the midguts of WT bacterial-infected flies in a
PLCb-dependent manner, but that escargot-positive cells were
significantly reduced in the midguts of URA bacterial-infected
flies (Figure 4B). Because ISCs are the sole group of dividing
cells in the midgut, we further examined the number of dividing
cells using an antiphosphorylated histone 3 (PH3) antibody to
quantitate the mitotic activity. The results showed that the
number of PH3-positive cells was clearly reduced following
URA pathogen infection when compared to WT pathogen
infection (Figures 4C and S4A). When we examined Su(H)Gbe-
lacZ (a specific marker for enteroblasts) and Prospero (a specific
marker for enteroendocrine cells), we found that WT pathogen
infection but not URA pathogen infection increased the number
of enteroblasts in a PLCb-dependent manner (Figures 4D and
S4B). However, no difference in the number of enteroendocrine
cells was observed between WT-pathogen-infected gut and
URA-pathogen-infected gut (Figure 4D). Consistent with this
impaired epithelial cell renewal process observed in the URA
pathogen infection, we found more pronounced apoptosis inthe URA-pathogen-infected gut compared to that seen in
WT-pathogen-infected gut (Figure S4C). Because the expres-
sion of cytokine Unpaired-3 (Upd3) in enterocytes and sub-
sequent activation of Janus kinase signal transducers and
activators of transcription (JAK-STAT) signaling in ISCs and
enteroblasts are known to be essential for enterocyte differenti-
ation (Buchon et al., 2009a; Cronin et al., 2009; Jiang et al.,
2009), we examined whether bacterial-derived uracil is required
for Upd3-JAK-STAT signaling activation. Analysis of reporter
transgenic flies showed that the number of cells showing Upd3
expression and subsequent STAT activation was clearly reduced
following URA pathogen infection when compared to WT
pathogen infection (Figure 4E). Importantly, either coingestion
of uracil with URA strain or ingestion of functionally rescued
URA strain was sufficient to restore infection-induced Upd3-
JAK-STAT signaling activation, ISC proliferation, and differentia-
tion as well as enteroblast accumulation (Figures 4B–4E).
Because pathogen-induced Upd3-JAK-STAT pathway activa-
tion was abolished in the absence of PLCb (Figure 4E), we
could conclude that the bacterial-derived uracil activates the
PLCb-DUOX-ROS pathway, which in turn acts as an upstream
event of the Upd3-JAK-STAT pathway for infection-induced
epithelial cell renewal. Furthermore, uracil ingestion alone was
sufficient to trigger the Upd3-JAK-STAT pathway activation
and epithelial cell renewal process in a PLCb-dependent manner
(Figures S5A–S5E). All of these results together indicate that
bacterial-derived uracil is the key factor responsible for bacte-
rial-modulated ISC turnover and the epithelial cell renewal pro-
gram for gut cell homeostasis during gut infection.
Recognition of Pathogen-Derived Uracil Is Required for
Host Survival during Gut Infection
As gut immune responses were virtually abolished in the case of
infectionwith URA pathogen, we examined the bacterial persis-
tence and host survival rate following gut infection with these
bacteria. When we examined the persistence of these bacteria
in the gut, we found that the URA pathogen persisted longer
than theWT pathogen in themidgut region (Figure 5A). No signif-
icant difference in terms of bacterial persistence was observed
between WT and URA pathogens in the anterior and posterior
part of the digestive tract (i.e., crop and hindgut, respectively)
(data not shown), suggesting that ingested bacteria are mainly
controlled by uracil-modulated gut immunity in the midgut. The
prolonged persistence of URA pathogen was abolished when
the flies were subjected to coingestion of URA pathogen with
uracil or ingestion of functionally rescuedURA strain (Figure 5A).
Importantly, we found that flies were more susceptible to infec-
tionwith URA pathogen, showing a poor survival rate postinfec-
tion, whereas the flies were not adversely affected by infection
with WT pathogen or other nucleobase auxotrophic mutants
(Figure 5B). Furthermore, we found that coingestion of uracil
with URA strain or ingestion of a functionally rescued URA
strain was sufficient to restore the host survival rate (Figure 5B),
demonstrating that URA-pathogen-induced pathology was
due to a lack of uracil in the gut lumen. Taken together, these
results demonstrate that host survival against gut infection
depends on recognition of pathogen-derived uracil and subse-
quent activation of DUOX-dependent gut immunity.Cell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc. 803
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Figure 4. Pathogen-Derived Uracil Is Required for DUOX-Dependent Microbicidal ROS Generation and Intestinal Stem Cell Homeostasis
(A) Reduced ROS production by URA pathogen infection. WT pathogen (E. carotovora) and URA pathogen (E. carotovora-pyrE::Tn5) were used.
(B–E) Bacterial-derived uracil controls the epithelial cell renewal program. All analyses were performed under a w1118 (Control) and a PLCb mutant (PLCb/)
background. Analysis of escargot-positive cells in the anterior midgut (B) was performed (at 22 hr postingestion) using flies carrying escargot-GAL4 > UAS-GFP.
Analysis of ISC proliferation by PH3 staining (C) and enteroblast differentiation (D) was performed at 22 hr postingestion. Flies carrying Su(H)Gbe-LacZ were
used to analyze Su(H)Gbe-LacZ and Prospero. The relative cells number of LacZ-positive or Prospero-positive cells was determined by counting the number of
(legend continued on next page)
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Chronic Activation of the DUOX-Dependent Gut
Immunity by Long-Term Uracil Contact Is Detrimental to
the Host
ROS dysregulation has a critical impact on the pathogenesis
of many important diseases in mucosal epithelia (Grisham,
1994; Rokutan et al., 2008). Considering the DUOX-activating
and ROS-generating ability of bacterial uracil, we hypothe-
sized that constitutive exposure to uracil could produce
harmful effects on host physiology. Because it is known that
PLCb/ and DUOX-RNAi flies have a short life span under
conventional rearing conditions but a normal life span under
germ-free conditions (Ha et al., 2009a), germ-free animals
were used to examine host physiology following long-term
ingestion of uracil. We found an extensive apoptosis in gut
cells, which ultimately led to the lethality of control flies in a
dose-dependent manner (Figures 5C, 5D, S5F, and S5G).
Importantly, this uracil-induced host pathology was com-
pletely absent in PLCb/ or DUOX-RNAi flies (Figures 5C,
5D, S5F, and S5G), indicating that uracil induces host cellular
damage in a PLCb-DUOX-dependent manner. Taken together,
these findings showed that chronic activation of the
PLCb-DUOX signaling-dependent gut immunity by long-term
uracil contact is indeed detrimental to the host due to the
excess ROS generation. Because indigenous gut microbiota
permanently reside in association with the peritrophic mem-
brane of the midgut epithelia, the above results imply that
a gut-dwelling autochthonous bacteria releasing uracil in a
constitutive manner may act as a colitogenic factor leading to
host pathology.
Chronic Activation of the DUOX-Dependent Gut
Immunity due to Long-Term Uracil Release from
Autochthonous Bacteria Is the Cause of Pathogenesis
Although some gut symbiotic microbiota are generally beneficial
to the host physiology, others can also lead to host pathogenesis
in certain circumstances, such as intestinal dysbiosis, a condi-
tion whereby an overgrowth of one or more normal species
making up the microflora causes intestinal dysfunction and dis-
eases (Garrett et al., 2010; Sokol and Seksik, 2010). Although
such abnormalities of microbiota have been associated with
many diseases including the inflammatory bowel disease
(Garrett et al., 2010; Sokol and Seksik, 2010), the molecular
mechanism by which intestinal dysbiosis causes host pathology
is poorly understood. In Drosophila, it was previously demon-
strated that overactivation of IMD-dependent immunity can
induce intestinal dysbiosis leading to an overgrowth ofGlucono-
bacter morbifer G707T, a minor member of the natural gut
microflora (Roh et al., 2008; Ryu et al., 2008). The overgrowth
of G. morbifer acts as a direct cause of gut pathology and
host lethality (Ryu et al., 2008). When the G. morbifer popula-
tion is dominant in the gut (e.g., in the absence of other
commensal community members, such as in the case of germ-LacZ-positive or Prospero-positive cells per 100 DAPI-positive cells in multiple
Upd3-gal4 > UAS-GFP or 2XSTAT-GFP were used at 4 hr postingestion.
In the rescue experiment (A–E), coingestion of 1 nM uracil with URA strain (+uraci
gene (+pyrE) was performed. Data in (A), (C), and (D) were analyzed using an ANOV
**p < 0.005, ***p < 0.001). See also Figures S3, S4, and S5.free animals monoassociated with G. morbifer), we observed
thatG. morbifer colonized the midgut region of the intestine (Fig-
ure S6A).Whenwe examined the ROS production inG.morbifer-
monoassociated animals, we found chronic ROS generation
accompanying severe gut cell apoptosis in a PLCb-DUOX
signaling-dependent manner (Figures 6A and 6B). We further
found that G. morbifer-induced ROS were colocalized with
colonized bacteria in a PLCb-DUOX-dependent manner, most
intensively in the anterior midgut region (Figure S6B). However,
other commensal members such as A. pomorum, C. intestini,
and L. plantarum could not induce chronic ROS generation
when each of these major bacteria was monoassociated with
germ-free animals (Figures 6A, S6B, and S6C). Because the
G. morbifer-induced chronic DUOX activation is likely the cause
of gut pathology, we hypothesized that the constitutive uracil
release due to the permanent presence of G. morbifer in the
gut was the major causal element of G. morbifer-induced
host pathogenesis. A mutation in the carbamoyl phosphate syn-
thetase (carA) is known to induce uracil auxotroph (Mergeay
et al., 1974). Therefore, we isolated a URA mutant strain of
G. morbifer carrying a mutation on the carA gene (G. morbifer-
carA::Tn5) using the transposon-based random mutant library
by screening 3,000 mutant strains (Figures S6D and S6E) in
order to validate the in vivo role of G. morbifer-derived uracil
on chronic DUOX activation. Importantly, monoassociation of
germ-free flies with G. morbifer-carA::Tn5 strain showed that
the this URA strain did not provoke constitutive ROS generation
in the gut (Figure 6C) and led to a significantly reduced gut
apoptosis (Figure 6D), which was in contrast to its parental
G. morbifer strain. When we examined the colony-forming units
(CFUs) of colonized bacteria in the guts, we found that the
G. morbifer-carA::Tn5 strain colonized gut epithelia as efficiently
as the WT G. morbifer strain (Figure 6E), confirming that healthy
host phenotypes found in the gut of animals monoassociated
with G. morbifer-carA::Tn5 were not due to the reduction of
colonizing bacterial numbers. When we examined the survival
rate of G. morbifer-monoassociated flies, we found that the
G. morbifer strain leads to early host death (Figure 6F), showing
its pathogenic nature. Importantly, however, G. morbifer-carA::
Tn5-monoassociated flies showed survival rates that were com-
parable to those of the control animals (Figure 6F). G. morbifer-
induced host mortality observed in control flies was abolished
in the absence of the PLCb-DUOX pathway because we
observed no difference in the survival rate between G. morbifer
monoassociation and G. morbifer-carA::Tn5 monoassociation
in the case of DUOX-RNAi or PLCb/ animals (Figure 6F),
demonstrating that G. morbifer-induced disease phenotypes
can be effectively reversed by diminishing either bacterial uracil
production or host DUOX activity. Furthermore, monoassocia-
tion of Gram-positive L. brevis, the other minor member of natu-
ral gut microflora, with germ-free animals showed that L. brevis
can also provoke a disease phenotype due to uracil-inducedimages. Upd3 promoter activity and STAT reporter activity (E). Flies carrying
l) or ingestion with the genetically rescued URA strain by expressing functional
A followed by the Tukey post hoc test; values represent mean ±SEM (*p < 0.05,
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See also Figure S5.chronic DUOX activation (Figure S7) similar to that seen
in G. morbier-monoassociated animals. Taken together, we
conclude that the steady release of uracil from two minor806 Cell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc.commensal bacteria and the consequent chronic activation
of PLCb-DUOX signaling-dependent gut immunity acts as a
direct cause of colitogenesis and host mortality.
DISCUSSION
Successful gut-microbe homeostasis is believed to be achieved
as a result of a delicate reciprocal interaction between different
microorganisms and gut immunity (Artis, 2008; Sansonetti,
2004). The present study demonstrates that uracil rather than
conventional MAMPs such as peptidoglycan acts as a
microbe-derived factor that modulates DUOX-dependent gut
immunity in Drosophila. Given that each bacterium likely has a
distinct level of uracil release (i.e., URA+ or URA bacteria) as
well as a distinct gut-colonizing ability (i.e., allochthonous or
autochthonous bacteria), the intensity and duration of DUOX-
dependent ROS production in the gut lumen likely varies among
four different types of bacterial contacts (Figures 7A–7D). It
should be noted that the activation of DUOX-dependent gut
immunity is completely dependent on the presence of bacterial
uracil, whereas the bacterial gut-colonization ability conferred
by innate characteristics of a particular bacterium (i.e., allochth-
onous or autochthonous bacteria) is a uracil-independent event.
To achieve gut-microbe homeostasis, the host should mount
adequate DUOX-dependent gut immunity by sensing uracil for
transient ROS production and repair of pathogen-induced gut
damage to counteract allochthonous bacteria (see Figure 7A
for a model). Under this specific immune homeostatic condition,
opportunistic E. carotovora pathogen could not normally harm
host physiology. Because the mutation of a single gene affecting
uracil levels in E. carotovora is sufficient to produce a gain-of-
virulence phenotype leading to host lethality (Figure 5B; see
also Figure 7B for a model), uracil recognition is of central impor-
tance in Drosophila DUOX-dependent gut immunity. In addition,
because both DUOX-dependent ROS generation and epithelial
cell renewal programs are essential features of gut immunity
for host survival during gut infection (Buchon et al., 2009a; Chat-
terjee and Ip, 2009; Cronin et al., 2009; Ha et al., 2005, 2009a,
2009b; Jiang et al., 2009), the absence of uracil-induced DUOX
activation during URA pathogen infection resulting in insuffi-
cient clearance of URA pathogen and impaired repair of path-
ogen-induced intestinal damage is likely the cause of death.
Immune tolerance to gut-colonizing autochthonous bacteria is
essential for long-term cohabitation between host and microbial
cells, which remains one of the great enigmas in gut immunity.
Excess immune activation to gut microbiota may lead to severe
pathogenesis in themucosa (Bae et al., 2010; Garrett et al., 2010;
Ryu et al., 2008; Sokol and Seksik, 2010). We demonstrated that
the uracil-deficient nature of major symbiotic gut microbes is
highly beneficial, enabling the gut to harbor beneficial microbial
cells without immune activation (see Figure 7D for a model). Of
note, some conditionally pathogenic autochthonous bacteria
(i.e., pathobionts such as G. morbifer and L. brevis) are normally
quiescent but are able to provoke chronic inflammation under
dysbiosis conditions (e.g., as in the case of G. morbifer domi-
nance in Caudal loss-of-function flies [Ryu et al., 2008] or
G.morbifer-monoassociated gnotobiotic flies used in this study).
This situation is reminiscent of inflammatory bowel diseases,
wherein some previously commensal resident bacteria cause
gut pathology under certain conditions (Andoh et al., 2009; Gar-
rett et al., 2010; Sokol and Seksik, 2010). Our study demon-
strated that URA+ autochthonous bacteria, such as G. morbiferand L. brevis, can act as colitogenic pathobionts due to their
constant uracil release and subsequent chronic DUOX activation
(Figures 6 and S7; see also Figure 7C for a model). Deletion of
a single microbial gene involved in uracil production (i.e.,
G. morbifer-carA::Tn5 and L. brevisDcarA) is sufficient to induce
a phenotypic shift from a colitogenic to commensal type (Figures
6 and S7; see also Figure 7D for a model), suggesting that uracil
excretion may be a defining feature of pathogenic versus
commensal bacteria. Based on these observations, one can
speculate that the shift to uracil production in benign commensal
bacteria under certain gut environments may render them to be
colitogenic.
One of the fundamental questions is why some bacteria
release uracil, whereas others do not. It has been shown for
some time that free nucleobases are not normally present intra-
or extracellularly in bacteria (Rinas et al., 1995). However, the
excretion of free nucleobases, especially uracil and xanthine
(but not other nucleobases), can be observed in Escherichia
coli in response to entry into the stationary phase or in response
to the perturbation of balanced growth conditions, such as
energy-source downshifts (Rinas et al., 1995). Alternatively, bac-
terial cell death and lysis under unfavorable growth conditions
may release uracil, and if so, the bacterial growth/death rate in
an intestinal niche may influence in vivo uracil release. As uracil
release is likely influenced by various environmental conditions,
such as nutrition availability and cell density, uracil release in a
natural niche may be different from that found in laboratory cul-
ture conditions. It was proposed that free uracil may originate
from the breakdown of stable RNA, such as ribosomal RNA,
and that uracil release could be considered as an indicator of a
specific metabolic and physiological state of the bacterial com-
munity (Rinas et al., 1995). Interestingly, it was found that uracil
auxotrophic mutant strains (such as carA and pyrE mutants) of
Pseudomonas aeruginosa showed decreased biofilm formation
and quorum-sensing phenotypes, which can be restored by
exogenous addition of free uracil (Ueda et al., 2009). Such
uracil-modulated bacterial responses are known to enhance
bacterial virulence that is potentially threatening to host fitness
(Attila et al., 2009). It was hypothesized that uracil may act as a
bacterial secondary messenger involved in cellular fitness to sur-
vive under different environmental conditions (Ueda et al., 2009).
Although the exact physiological significance of uracil release in
bacteria remains to be elucidated, it is tempting to speculate
that Drosophila gut epithelial cells have evolved to perceive a
change in the bacterial metabolic state through uracil recognition
and subsequently mount uracil-induced immunity to efficiently
antagonize bacteria before acquiring the resistance and/or viru-
lencemechanism. In this context, symbiotic autochthonous bac-
teria may have evolved to abolish and/or reduce uracil release
in vivo, possibly by modifying the mechanism of uracil excretion,
thereby adapting to an intestinal niche. Further in-depth investi-
gation of the detailed bacterial mechanisms controlling uracil
release will be needed to better understand the differential regu-
lation of uracil release between commensal and pathogenic
bacteria.
Profiling of commensal community members of Drosophila
showed that different bacterial members (mostly belonging
to a subset of bacterial families, such as Acetobacteraceae,Cell 153, 797–811, May 9, 2013 ª2013 Elsevier Inc. 807
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Figure 6. Gut-Dwelling G. morbifer Can Act as a Colitogenic Flora due to its Constant Uracil Release and Subsequent Chronic DUOX
Activation
(A and B) ROS generation and gut cell apoptosis byG. morbifer. The fly genotypes are described in Figure 2F. Basal levels of intestinal ROSwere measured in GF
animals (GF-control and GF-DUOX-RNAi) monoassociated with each of commensal bacteria (A). The apoptosis index (B) is shown.
(C and D) ROS production and gut cell apoptosis are abolished in GF-control animals monoassociated with the URAmutant strain ofG. morbifer. Basal levels of
intestinal ROS (C) and the apoptosis index (D) were determined.
(E) The URAmutant strain of G. morbifer colonizes gut epithelia as efficiently as WTG. morbifer. CFUs were determined using midguts (n = 15) from GF-control
animals monoassociatedwithG.morbifer orG.morbifer-carA::Tn5 (day = 13). Data were analyzed using theMann-WhitneyU test. In box plot diagrams, the black
lines and boxes represent the median and first and third quartile values.
(legend continued on next page)
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Figure 7. Model of Uracil-Modulated Gut-
Microbe Symbiosis and Gut-Microbe
Pathogenesis
(A–D) Four different types of bacterial contacts are
shown. (A) Regulated activation of gut immunity in
response to URA+ allochthonous bacterial con-
tacts. (B) Insufficient activation of gut immunity
in response to URA allochthonous bacterial
contacts. (C) Chronic activation of gut immunity
in response to URA+ autochthonous bacterial
contacts. (D) Immune tolerance and gut-microbe
symbiosis in response to URA autochthonous
bacterial contacts. See Discussion for more
details.Lactobacillaceae, Enterococcaceae, and Enterobacteriaceae)
with high taxonomic diversity at the species level were observed
among different laboratory and natural Drosophila populations
(Chandler et al., 2011; Corby-Harris et al., 2007; Cox and Gil-
more, 2007; Ren et al., 2007; Ryu et al., 2008; Storelli et al.,
2011; Wong et al., 2011). At present, the exact autochthonous
bacterial strains acting as symbiotic/commensal bacteria or
pathobionts (such as G. morbifer and L. brevis in this study) in
the Drosophila gut is largely unknown. Considering the essential
role of bacterial-derived uracil as a modulator of gut-microbe
homeostasis, further investigation of the uracil-releasing ability,
DUOX-activating ability, and gut-colonizing ability of each bacte-
rial member in a given Drosophila gut environment will be
required to better understand the physiological characteristics
(e.g., autochthonous or allochthonous bacterium, as well as
symbiont or pathobiont) of each bacterium in the gut.(F) Chronic activation of PLCb-DUOX pathway by G. morbifer-derived uracil is the direct cause of host m
data showed a significant difference in survival between G. morbifer monoassociation and G. morbifer-carA
(p < 0.001) but not in the case of DUOX-RNAi flies (p = 0.59) or PLCb/ flies (p = 0.47).
Data were analyzed using an ANOVA followed by Tamhane’s T2 post hoc test (A, C, and D) or by the Tuke
(*p < 0.05, **p < 0.005, ***p < 0.001). See also Figures S6 and S7.
Cell 153, 797–Recently,C. elegansDUOX (Ce-DUOX)
was also shown to be required for
pathogen-induced ROS production as a
protective host-innate immune mecha-
nism (Hoeven et al., 2011), suggesting
the possible existence of a common
ligand for DUOX activation in response
to pathogens. In mammals, DUOX is
known to be expressed in microbe-con-
tacting barrier epithelia such as the bron-
chial and intestinal epithelia (El Hassani
et al., 2005; Geiszt et al., 2003). Although
it remains to be validated in an in vivo
mammalian animal model, there is
accumulating evidence suggesting that
mammalian DUOX plays an important
role in mucosal immunity (Moskwa
et al., 2007; Rada and Leto, 2008).
Because our preliminary data showed
that uracil was also able to activateDUOX-dependent ROS generation in C. elegans and human
mucosal epithelial cells, uracil-induced DUOX activation seems
to be conserved in metazoan epithelial cells. Although a much
more complex environment, it would be interesting to investigate
whether a similar mechanism is involved in inflammatory pathol-
ogies in the mammalian gut.
Given that many mucosal inflammatory diseases arise from
abnormal mucosa-microbe interactions (Artis, 2008; Garrett
et al., 2010; Sansonetti, 2004; Sokol and Seksik, 2010) and that
ROS dysregulation plays a critical role in the pathogenesis of
these diseases (Bae et al., 2010; Grisham, 1994; Rokutan et al.,
2008), the discovery of bacterial-derived uracil as an activator
of gut-innate immunity and as a causal agent of colitogenesis
will greatly help in better understanding the mucosal strategy
of pathogen clearance versus commensal tolerance as well as
the etiology of colitis associated with intestinal dysbiosis.ortality. A log rank analysis on the Kaplan-Meier
::Tn5 monoassociation in the case of control flies
y post hoc test (B); values represent mean ±SEM
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EXPERIMENTAL PROCEDURES
Fly Strains and Rearing
The fly lines used in this study are described in Extended Experimental Proce-
dures. Flies were maintained at 25C. The composition of standard corn meal
agar medium was described previously (Shin et al., 2011). Axenic standard
corn meal agar media were used for the experiments with germ-free animals
or germ-free animals monoassociated with a commensal bacterium. Bokinin
and propionic acid were omitted from the axenic media.
Bacterial Strains and Culture Conditions
E. carotovora subsp. carotovora-15 was obtained from Bruno Lemaitre (Bu-
chon et al., 2009b). Commensalibacter intestini A911T, Gluconobacter morbi-
fer G707T, Acetobacter pomorum, Lactobacillus plantarum, and Lactobacillus
brevis were isolated from our laboratory fly stocks (Roh et al., 2008; Ryu et al.,
2008). Human-isolated bacterial strains were obtained from the Korean
Collection for Type Cultures. We generated two URA mutant bacteria,
E. carotovora-pyrE::Tn5 and G. morbifer-carA::Tn5, by using Tn5-mediated
random mutant libraries for E. carotovora and G. morbifer. Detailed methods
for Tn5-mediated random mutagenesis and screening strategy to isolate the
URAmutant are described in Extended Experimental Procedures and shown
in Figures S3 and S6. E. carotovora-pyrE::Tn5-pyrE strain was generated by
introducing pTac3-pyrE into E. carotovora-pyrE::Tn5 strain. The pTac3 expres-
sion vector containing apramycin resistance gene is a modified version of
pTac1 vector (Koo et al., 2003). All bacteria were cultured at 30C. Appropriate
antibiotics were added at 50 mg/ml (apramycin) and 30 mg/ml (kanamycin).
In Vivo ROS Detection in Intestinal Epithelia
R19S, a recently developed HOCl-specific rhodamine-based dye, was used in
this experiment (Chen et al., 2011). The detailed methods used to measure
bacterial-induced ROS and basal ROS levels are described in Extended
Experimental Procedures.
Statistical Analysis
Comparisons of two samples were made by using either the Student’s t test or
the Mann-Whitney U test. Comparisons of multiple samples were made by
ANOVA. The Kaplan-Meier log-rank test was used for the statistical analysis
of fly survival experiments. p values of less than 0.05 were considered statis-
tically significant. SPSS software (Chicago, IL, USA) was used for all analyses.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2013.04.009.
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